In addition, Oat3 and Oct2 protein expression levels were increased 1.3- and 1.4-fold, respectively, in the kidneys of APP/PS1 transgenic mice compared with those in wild-type mice, which may have affected drug elimination in this AD model [78]. This evidence concerns the gene APP and Alzheimer disease.